Andrew has over 15 years of experience in biotechnology, pharmaceuticals, diagnostics, and other healthcare sectors. His team specializes in growth strategy projects pertaining to cutting-edge medical technologies. Since 2012, his team has conducted over 100 projects for executives in the C suite, commercial franchises, corporate development, and R&D, and spanning nearly every therapeutic area undergoing innovation. In this episode, he gives an in-depth view of the biotech industry. Andrew can be reached through LinkedIn or you can email him at [email protected]. And you can listen to more from Andrew on Episode 355. Key points include: 01:09: A quick explanation of biotech, agricultural biotech, and industrial biotech 08:09: The difference between pharma and biotech 12:28: Drugs that fall into the biotech category 18:45: Differences in delivery methodologies between small molecule and more complex molecules 24:31: The different roles and functions at biotech and pharma companies Unleashed is produced by Umbrex, which has a mission of connecting independent management consultants with one another, creating opportunities for members to meet, build relationships, and share lessons learned. Learn more at www.umbrex.com.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related